Subscribe to JDD
The Journal of Drugs in Dermatology (JDD) continues to be a leading dermatology journal, presenting original articles, award-winning case studies, clinical trial reviews and clearance updates, drugs and devices, and special content geared toward medical residents and other allied health professionals. JDD is a top-tier, highly cited, peer-reviewed publication that has been indexed with MEDLINE®/PubMed® since Issue 1-1.
JDD utilizes an unbiased, balanced peer-review process in order to maintain high standards of content. Articles are reviewed by the Editorial Board of more than 160 renowned experts, from key opinion leaders to well-known clinicians.
Learn more about the benefits you'll receive as a JDD subscriber.